Phase IV, Open-Label, Multicenter, Randomized Study Comparing Mycophenolate Mofetil (MMF) Dose Adjustment Based on Blood MPA Concentration to Standard Care Treatment With MMF in Renal Transplant Recipients Receiving Tacrolimus.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 31 Mar 2010 Actual initiation date (Aug 2008) added as reported by ClinicalTrials.gov.
- 31 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 12 Sep 2008 New trial record.